96
Views
0
CrossRef citations to date
0
Altmetric
CASE REPORT

Concomitant of Cryptococcal Meningitis and COVID-19 in a Female Patient with Primary Nephrotic Syndrome and Type 2 Diabetes

& ORCID Icon
Pages 279-285 | Received 27 Nov 2023, Accepted 26 Jan 2024, Published online: 31 Jan 2024

References

  • Iyer KR, Revie NM, Fu C, et al. Treatment strategies for cryptococcal infection: challenges, advances and future outlook. Nat Rev Microbiol. 2021;19(7):454–466. doi:10.1038/s41579-021-00511-0
  • Fisher KM, Montrief T, Ramzy M, et al. Cryptococcal meningitis: a review for emergency clinicians. Intern Emerg Med. 2021;16(4):1031–1042. doi:10.1007/s11739-020-02619-2
  • Temfack E, Boyer-Chammard T, Lawrence D, et al. New insights into Cryptococcus spp. biology and cryptococcal meningitis. Curr Neurol Neurosci Rep. 2019;19(10):81. doi:10.1007/s11910-019-0993-0
  • Ma H, Wang X, Yan H, et al. Dual intracranial infection with nocardia farcinica and Cryptococcus neoformans diagnosed by next-generation sequencing in a patient with nephrotic syndrome: a case report. Medicine. 2022;101(35):e30325. doi:10.1097/MD.0000000000030325
  • Nagotkar L, Shanbag P, Mauskar A, et al. Fulminant intracranial hypertension due to cryptococcal meningitis in a child with nephrotic syndrome. Indian J Crit Care Med. 2011;15(3):176–178. doi:10.4103/0972-5229.84905
  • Qu J, Zhou T, Zhong C, et al. Comparison of clinical features and prognostic factors in HIV-negative adults with cryptococcal meningitis and tuberculous meningitis: a retrospective study. BMC Infect Dis. 2017;17(1):51. doi:10.1186/s12879-016-2126-6
  • Lao M, Li C, Li J, et al. Opportunistic invasive fungal disease in patients with type 2 diabetes mellitus from Southern China: clinical features and associated factors. J Diabetes Investig. 2020;11(3):731–744. doi:10.1111/jdi.13183
  • Nsenga L, Kajjimu J, Olum R, et al. Cryptococcosis complicating diabetes mellitus: a scoping review. Ther Adv Infect Dis. 2021;8:20499361211014769. doi:10.1177/20499361211014769
  • Temfack E, Rim JJB, Spijker R, et al. Cryptococcal antigen in serum and cerebrospinal fluid for detecting cryptococcal meningitis in adults living with human immunodeficiency virus: systematic review and meta-analysis of diagnostic test accuracy studies. Clin Infect Dis. 2021;72(7):1268–1278. doi:10.1093/cid/ciaa1243
  • Li Z, Liu Y, Chong Y, et al. Fluconazole plus flucytosine is a good alternative therapy for non-HIV and non-transplant-associated cryptococcal meningitis: a retrospective cohort study. Mycoses. 2019;62(8):686–691. doi:10.1111/myc.12944
  • Chen J, Chen P. Cryptococcal meningitis in patients with lupus nephritis. Clin Rheumatol. 2020;39(2):407–412. doi:10.1007/s10067-019-04844-3
  • Liang L, Liang Z, She D, et al. A case-control study of human immunodeficiency virus-negative patients with cryptococcemia and cryptococcal meningitis in a Chinese tertiary care hospital during 10 years. J Int Med Res. 2021;49(1):300060520984658. doi:10.1177/0300060520984658
  • Murphy LS, Lacy AJ, Smith AT, et al. Cryptococcal meningitis in an immunocompetent patient. Am J Emerg Med. 2020;38(11):2492.e1–2492.e3. doi:10.1016/j.ajem.2020.05.115
  • Liu J, Li M, Liang JY, et al. Autoimmune diseases in HIV-negative cryptococcal meningitis. Future Microbiol. 2021;16(16):1251–1259. doi:10.2217/fmb-2020-0318
  • Wykowski J, Galagan SR, Govere S, et al. Cryptococcal antigenemia is associated with meningitis or death in HIV-infected adults with CD4 100–200 cells/mm3. BMC Infect Dis. 2020;20(1):61. doi:10.1186/s12879-020-4798-1
  • Ngan NTT, Flower B, Day JN. Treatment of cryptococcal meningitis: how have we got here and where are we going? Drugs. 2022;82(12):1237–1249. doi:10.1007/s40265-022-01757-5
  • Li J, Zhang Q, Su B. Clinical characteristics and risk factors of severe infections in hospitalized adult patients with primary nephrotic syndrome. J Int Med Res. 2017;45(6):2139–2145. doi:10.1177/0300060517715339
  • Moosa MS, Lessells RJ. Toward simpler, safer treatment of cryptococcal meningitis. N Engl J Med. 2022;386(12):1179–1181. doi:10.1056/NEJMe2201150
  • Loyse A, Burry J, Cohn J, et al. Leave no one behind: response to new evidence and guidelines for the management of cryptococcal meningitis in low-income and middle-income countries. Lancet Infect Dis. 2019;19(4):e143–e147. doi:10.1016/S1473-3099(18)30493-6
  • Acharya R, Khanal K, Upadhyaya P, et al. Diabetes mellitus as a risk factor for cryptococcal meningitis in immunocompetent. IDCases. 2020;22:e00988. doi:10.1016/j.idcr.2020.e00988
  • Horiya M, Anno T, Kawada M, et al. Pyogenic psoas abscess on the dorsal side, and bacterial meningitis and spinal epidural abscess on the ventral side, both of which were induced by spontaneous discitis in a patient with diabetes mellitus: a case report. J Diabetes Investig. 2021;12(7):1301–1305. doi:10.1111/jdi.13461
  • Viallard JF. Management of hypogammaglobulinemia. Rev Med Interne. 2023;44(3):133–138. French. doi:10.1016/j.revmed.2023.01.010
  • Constantinescu AR, Mattoo TK, Smoyer WE, et al. Clinical presentation and management of nephrotic syndrome in the first year of life: a report from the pediatric nephrology research consortium. Front Pediatr. 2022;10:988945. doi:10.3389/fped.2022.988945
  • Hu D, Zhang Q, Jiang W, et al. Cryptococcal meningitis: a rare complication in HIV-negative patients with nephrotic syndrome in A Chinese teaching hospital. Mycopathologia. 2020;185(6):959–969. doi:10.1007/s11046-020-00482-5
  • Su B, Zhang Q, Lv J. Cryptococcal meningitis in adult patients with primary nephrotic syndrome. Clin Nephrol. 2018;90(6):390–395. doi:10.5414/CN109384